Figure 2: Adjusted Cohen Mansfield Agitation Inventory score by treatment
group and time (higher scores indicate greater agitation)
CMAI

—♦— DCM
—•— PCC
—UC UC
Table 2: Annual Pharmaceutical Costs Per Resident
Mean, standard |
DCM |
PCC |
UC |
Total | |
Period |
Pre- Intervention |
598.44 (906.30) |
647.35 (790.39) |
473.25 (905.64) |
579.51 (868.34) |
Post- Intervention |
617.72 (955.06) |
597.89 (852.35) |
363.00 (852.75) |
541.45 (897.13) | |
Follow-up |
542.21 (883.32) |
560.49 (823.68) |
398.19 (871.16) |
508.10 (860.10) | |
Total |
587.31 (913.29) |
605.37 (818.91) |
414.96 (875.68) |
545.55 (874.88) |
Pair-wise t-tests were run on this information, investigating whether the
pharmaceutical costs per person at a time point were statistically significantly
different from the observed mean. In the nine pair-wise comparisons, none were
statistically significant at the 5% level. Therefore, as the mean difference between
More intriguing information
1. The name is absent2. NATIONAL PERSPECTIVE
3. A Pure Test for the Elasticity of Yield Spreads
4. The Role of Evidence in Establishing Trust in Repositories
5. ISO 9000 -- A MARKETING TOOL FOR U.S. AGRIBUSINESS
6. Benchmarking Regional Innovation: A Comparison of Bavaria, Northern Ireland and the Republic of Ireland
7. Distortions in a multi-level co-financing system: the case of the agri-environmental programme of Saxony-Anhalt
8. Crime as a Social Cost of Poverty and Inequality: A Review Focusing on Developing Countries
9. Initial Public Offerings and Venture Capital in Germany
10. Natural Resources: Curse or Blessing?